Factors Predictive of Selective Angioembolization Failure for Moderate- to High-grade Renal Trauma: A French Multi-institutional Study.


Journal

European urology focus
ISSN: 2405-4569
Titre abrégé: Eur Urol Focus
Pays: Netherlands
ID NLM: 101665661

Informations de publication

Date de publication:
Jan 2022
Historique:
received: 11 10 2020
revised: 21 12 2020
accepted: 08 01 2021
pubmed: 30 1 2021
medline: 15 4 2022
entrez: 29 1 2021
Statut: ppublish

Résumé

Angiography with selective angioembolization (SAE) is safe and effective in addressing bleeding in patients with renal trauma. However, there are no validated criteria to predict SAE efficacy. To evaluate factors predictive of SAE failure after moderate- to high-grade renal trauma. TRAUMAFUF was a retrospective multi-institutional study including all patients who underwent upfront SAE for renal trauma in 17 French hospitals between 2005 and 2015. The primary outcome was SAE efficacy, defined as the absence of repeat SAE, salvage nephrectomy, and/or death for each patient. Out of 1770 consecutive patients with renal trauma, 170 (9.6%) with moderate- to high-grade renal trauma underwent SAE. Overall upfront SAE was successful in 131 patients (77%) and failed in 39 patients: six patients died after the embolization, ten underwent repeat SAE, 22 underwent open nephrectomy, and one underwent open surgical exploration. In multivariate logistic regression analysis, gross hematuria (odds ratio [OR] 3.16, 95% confidence interval [CI] 1.29-8.49; p=0.015), hemodynamic instability (OR 3.29, 95% CI 1.37-8.22; p=0.009), grade V trauma (OR 2.86, 95% CI 1.06-7.72; p=0.036), and urinary extravasation (OR 3.49, 95% CI 1.42-8.83; p=0.007) were predictors of SAE failure. The success rate was 64.7% (22/34) for patients with grade V trauma and 59.6% (31/52) for those with hemodynamic instability. The study was limited by its retrospective design and the lack of a control group managed with either surgery or surveillance. We found that gross hematuria, hemodynamic instability, grade V trauma, and urinary extravasation were significant predictors of SAE failure. However, success rates in these subgroups remained relatively high, suggesting that SAE might be appropriate for those patients as well. Selective angioembolization (SAE) is a useful alternative to nephrectomy to address bleeding in patients with renal trauma. Currently, there are no validated criteria to predict SAE efficacy. We found that gross hematuria, hemodynamic instability, grade V trauma, and urinary extravasation were significant predictors of SAE failure.

Sections du résumé

BACKGROUND BACKGROUND
Angiography with selective angioembolization (SAE) is safe and effective in addressing bleeding in patients with renal trauma. However, there are no validated criteria to predict SAE efficacy.
OBJECTIVE OBJECTIVE
To evaluate factors predictive of SAE failure after moderate- to high-grade renal trauma.
DESIGN, SETTING, AND PARTICIPANTS METHODS
TRAUMAFUF was a retrospective multi-institutional study including all patients who underwent upfront SAE for renal trauma in 17 French hospitals between 2005 and 2015.
OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS METHODS
The primary outcome was SAE efficacy, defined as the absence of repeat SAE, salvage nephrectomy, and/or death for each patient.
RESULTS AND LIMITATIONS CONCLUSIONS
Out of 1770 consecutive patients with renal trauma, 170 (9.6%) with moderate- to high-grade renal trauma underwent SAE. Overall upfront SAE was successful in 131 patients (77%) and failed in 39 patients: six patients died after the embolization, ten underwent repeat SAE, 22 underwent open nephrectomy, and one underwent open surgical exploration. In multivariate logistic regression analysis, gross hematuria (odds ratio [OR] 3.16, 95% confidence interval [CI] 1.29-8.49; p=0.015), hemodynamic instability (OR 3.29, 95% CI 1.37-8.22; p=0.009), grade V trauma (OR 2.86, 95% CI 1.06-7.72; p=0.036), and urinary extravasation (OR 3.49, 95% CI 1.42-8.83; p=0.007) were predictors of SAE failure. The success rate was 64.7% (22/34) for patients with grade V trauma and 59.6% (31/52) for those with hemodynamic instability. The study was limited by its retrospective design and the lack of a control group managed with either surgery or surveillance.
CONCLUSIONS CONCLUSIONS
We found that gross hematuria, hemodynamic instability, grade V trauma, and urinary extravasation were significant predictors of SAE failure. However, success rates in these subgroups remained relatively high, suggesting that SAE might be appropriate for those patients as well.
PATIENT SUMMARY RESULTS
Selective angioembolization (SAE) is a useful alternative to nephrectomy to address bleeding in patients with renal trauma. Currently, there are no validated criteria to predict SAE efficacy. We found that gross hematuria, hemodynamic instability, grade V trauma, and urinary extravasation were significant predictors of SAE failure.

Identifiants

pubmed: 33509672
pii: S2405-4569(21)00009-2
doi: 10.1016/j.euf.2021.01.008
pii:
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

253-258

Informations de copyright

Copyright © 2021 European Association of Urology. Published by Elsevier B.V. All rights reserved.

Auteurs

Michael Baboudjian (M)

Department of Urology and Kidney Transplantation, Aix-Marseille University, APHM Conception Academic Hospital, Marseille, France. Electronic address: michael.baboudjian@ap-hm.fr.

Bastien Gondran-Tellier (B)

Department of Urology and Kidney Transplantation, Aix-Marseille University, APHM Conception Academic Hospital, Marseille, France.

Paul Panayotopoulos (P)

Department of Urology, University of Angers, Angers, France.

Marine Hutin (M)

Department of Urology, University of Montpellier, Montpellier, France.

Jonathan Olivier (J)

Department of Urology, University of Lille, Lille, France.

Marina Ruggiero (M)

Department of Urology, University of Paris Sud, CHU Bicetre, Paris, France.

Ines Dominique (I)

Department of Urology, University of Lyon, Lyon, France.

Clémentine Millet (C)

Department of Urology, University of Clermont-Ferrand, Clermont-Ferrand, France.

Sébastien Bergerat (S)

Department of Urology, University of Strasbourg, Strasbourg, France.

Lucas Freton (L)

Department of Urology, University of Rennes, Rennes, France.

Reem Betari (R)

Department of Urology, University of Amiens, Amiens, France.

Xavier Matillon (X)

Department of Urology, University of Lyon, Lyon, France.

Ala Chebbi (A)

Department of Urology, University of Rouen, Rouen, France.

Thomas Caes (T)

Department of Urology, University of Lille, Lille, France.

Pierre-Marie Patard (PM)

Department of Urology, University of Toulouse, Toulouse, France.

Nicolas Szabla (N)

Department of Urology, University of Caen, Caen, France.

Laura Sabourin (L)

Department of Urology, University of Clermont-Ferrand, Clermont-Ferrand, France.

Charles Dariane (C)

Department of Urology, University of Paris Descartes, Paris, France.

Cedric Lebacle (C)

Department of Urology, University of Paris Sud, CHU Bicetre, Paris, France.

Jerome Rizk (J)

Department of Urology, University of Lille, Lille, France.

Francois-Xavier Madec (FX)

Department of Urology, University of Nantes, Nantes, France.

Francois-Xavier Nouhaud (FX)

Department of Urology, University of Rouen, Rouen, France.

Xavier Rod (X)

Department of Urology, University of Nantes, Nantes, France.

Gaelle Fiard (G)

Department of Urology, University of Grenoble, Grenoble, France.

Benjamin Pradere (B)

Department of Urology, University of Tours, Tours, France.

Benoit Peyronnet (B)

Department of Urology, University of Rennes, Rennes, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH